SB 876: Chimeric Antigen Receptor T-cell Therapy
GENERAL BILL by Berman
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Senate Committee References:
- Banking and Insurance (BI)
- Judiciary (JU)
- Rules (RC)
Bill History
Date | Chamber | Action |
---|---|---|
2/19/2025 | Senate |
• Filed |
2/28/2025 | Senate |
• Referred to Banking and Insurance; Judiciary; Rules |
3/4/2025 | Senate |
• Introduced |